| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| S9083 |
Global fee urgent care centers |
10,589 |
9,888 |
$581K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,860 |
2,717 |
$31K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
346 |
342 |
$22K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
647 |
643 |
$21K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
1,930 |
1,733 |
$20K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
506 |
495 |
$15K |
| 99223 |
Prolong inpt eval add15 m |
243 |
239 |
$14K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,148 |
2,909 |
$13K |
| 93000 |
|
294 |
292 |
$6K |
| 99381 |
|
190 |
190 |
$5K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
94 |
93 |
$4K |
| 99233 |
Prolong inpt eval add15 m |
250 |
104 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,440 |
1,285 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
117 |
117 |
$3K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
92 |
91 |
$3K |
| 92551 |
|
211 |
209 |
$2K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
380 |
379 |
$1K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
60 |
56 |
$1K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
310 |
298 |
$993.12 |
| 99383 |
|
199 |
199 |
$651.36 |
| 99384 |
|
117 |
115 |
$455.84 |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
15 |
15 |
$362.10 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
678 |
676 |
$285.12 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
708 |
708 |
$259.14 |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
45 |
16 |
$187.10 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
144 |
144 |
$162.84 |
| 88720 |
|
32 |
32 |
$131.10 |
| 99442 |
|
34 |
28 |
$121.98 |
| 99382 |
|
87 |
87 |
$93.32 |
| 99188 |
|
511 |
507 |
$89.10 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
729 |
679 |
$78.74 |
| 99222 |
Initial hospital care, per day, moderate complexity |
25 |
25 |
$72.47 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
234 |
234 |
$43.41 |
| 96127 |
|
62 |
60 |
$23.80 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
460 |
448 |
$10.94 |
| 94760 |
|
2,290 |
2,162 |
$0.00 |
| 3080F |
|
50 |
49 |
$0.00 |
| 3079F |
|
151 |
151 |
$0.00 |
| 3075F |
|
88 |
87 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
45 |
45 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
16 |
16 |
$0.00 |
| 3074F |
|
282 |
275 |
$0.00 |
| 99070 |
|
21 |
21 |
$0.00 |
| A6222 |
Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing |
12 |
12 |
$0.00 |
| 1111F |
|
19 |
19 |
$0.00 |
| 81002 |
|
1,516 |
1,472 |
$0.00 |
| 3078F |
|
310 |
302 |
$0.00 |
| 81025 |
|
154 |
150 |
$0.00 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
15 |
15 |
$0.00 |
| G9920 |
Screening performed and negative |
329 |
328 |
$0.00 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
26 |
25 |
$0.00 |
| 3077F |
|
140 |
138 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
103 |
103 |
$0.00 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
14 |
14 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
45 |
45 |
$0.00 |